These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32649404)

  • 21. Efficacy of sarilumab in adult-onset Still's disease as a corticosteroid-sparing agent.
    Simeni Njonnou SR; Soyfoo MS; Vandergheynst FA
    Rheumatology (Oxford); 2019 Oct; 58(10):1878-1879. PubMed ID: 31056689
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.
    Thonhofer R; Hiller M; Just H; Trummer M; Siegel C; Dejaco C
    Rheumatol Int; 2011 Dec; 31(12):1653-6. PubMed ID: 21240503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case of adult onset Still's disease with mutations of the MEFV gene who is partially responsive to colchicine.
    Ou-Yang LJ; Tang KT
    Medicine (Baltimore); 2018 Apr; 97(15):e0333. PubMed ID: 29642170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adult-onset Still's Disease during Pregnancy Treated with Tocilizumab.
    Imaizumi C; Saito M; Abe F; Kaga H; Saito A; Nara M; Kameyama S; Miura H; Ogasawara H; Hirakawa T; Mizunuma M; Satoh M; Komatsuda A; Terada Y; Takahashi N
    Intern Med; 2022 Oct; 61(20):3137-3140. PubMed ID: 35283384
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of tocilizumab therapy in Korean patients with adult-onset Still's disease: a multicentre retrospective study of 22 cases.
    Song ST; Kim JJ; Lee S; Kim HA; Lee EY; Shin KC; Lee JH; Lee KH; Choi ST; Cha HS; Yoo DH
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S64-S71. PubMed ID: 27462914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rescued from desperation: adult-onset Still's disease with life-threatening interstitial lung disease and macrophage activation : Successful treatment by Tocilizumab.
    Zhang G; Liu W; Zhang X; Liu L
    Z Rheumatol; 2022 May; 81(4):335-338. PubMed ID: 34378080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adult-onset Still disease: treatment with biologic agents in refractory cases].
    Tejera B; Martínez-Morillo M; Riveros A; Olivé A
    Med Clin (Barc); 2013 Apr; 140(8):381-2. PubMed ID: 23273758
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease.
    Cavalli G; Tomelleri A; De Luca G; Campochiaro C; Dinarello CA; Baldissera E; Dagna L
    Arthritis Res Ther; 2019 Feb; 21(1):54. PubMed ID: 30760322
    [No Abstract]   [Full Text] [Related]  

  • 29. A 62-Year-Old Woman With Fever and Exanthema.
    Martín-Iglesias D; Antequera-Martín A; Barrios-Blandino A
    J Clin Rheumatol; 2019 Oct; 25(7):e106. PubMed ID: 31577654
    [No Abstract]   [Full Text] [Related]  

  • 30. Tocilizumab in adult-onset Still's disease: the Israeli experience.
    Elkayam O; Jiries N; Dranitzki Z; Kivity S; Lidar M; Levy O; Ablin J; Abu-Shakra M; Savargyl-Maman H; Padova H; Caspi D; Rosner I
    J Rheumatol; 2014 Feb; 41(2):244-7. PubMed ID: 24429168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful tocilizumab therapy for adult onset Still's disease with intractable conditions over ten years].
    Takahashi Y; Ochi H; Yanai A; Yamashita H; Itoh K; Mimori A
    Nihon Naika Gakkai Zasshi; 2010 Jan; 99(1):130-2. PubMed ID: 20196484
    [No Abstract]   [Full Text] [Related]  

  • 32. Interleukin-18 in adult-onset Still's disease: treatment target or disease activity indicator?
    Nagashima T; Iwamoto M; Matsumoto K; Minota S
    Intern Med; 2012; 51(4):449; author reply 451. PubMed ID: 22333388
    [No Abstract]   [Full Text] [Related]  

  • 33. [The prognosis and treatment of Still's disease in adults].
    Holgado S; Casado E; Olivé A; Tena X
    Med Clin (Barc); 1999 Mar; 112(9):356. PubMed ID: 10220769
    [No Abstract]   [Full Text] [Related]  

  • 34. Infliximab in a case of early adult-onset Still's disease.
    Olivieri I; de Stefano G; Padula A; La Gala A; de Stefano C
    Clin Rheumatol; 2003 Oct; 22(4-5):369-70. PubMed ID: 14579170
    [No Abstract]   [Full Text] [Related]  

  • 35. Tocilizumab for multirefractory adult-onset Still's disease.
    De Bandt M; Saint-Marcoux B
    Ann Rheum Dis; 2009 Jan; 68(1):153-4. PubMed ID: 19088261
    [No Abstract]   [Full Text] [Related]  

  • 36. Successful slow tocilizumab desensitization in a patient with adult onset Still disease.
    Erdogan T; Yasar Bilge NS; Kasifoglu T
    Biologicals; 2018 Sep; 55():17-18. PubMed ID: 30017556
    [No Abstract]   [Full Text] [Related]  

  • 37. Adult-Onset Still's Disease: AClassic Presentation of a RareIllness.
    Kamboj AK; Ryan SM; Enzler MJ
    Am J Med; 2018 Oct; 131(10):e413-e414. PubMed ID: 29906427
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of tocilizumab on preventing relapses in adult-onset Still's disease: A retrospective, single-center study.
    Nishina N; Kaneko Y; Kameda H; Takeuchi T
    Mod Rheumatol; 2015 May; 25(3):401-4. PubMed ID: 25401229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of adult onset Still's disease with flare of arthritis.
    Sen K; Ghosh UC; Mukherjee AK; Ghosal A; Pandey UK
    J Indian Med Assoc; 2013 Feb; 111(2):132-4. PubMed ID: 24003576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 and adult-onset Still's disease as part of hyperferritinemic syndromes.
    Kawasaki T; Ooka S; Mizushima M; Nakamura Y; Ikeda H; Sakurada T; Suzuki S; Yamazaki K; Goto Y; Sakurai K; Yukitaka Y; Kiyokawa T; Tonooka K; Kunishima H; Kawahata K
    Mod Rheumatol Case Rep; 2022 Jan; 6(1):101-105. PubMed ID: 34592766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.